(IMAX) Imax - Ratings and Ratios
Large Screens, Film Distribution, Audio Technology, Systems, Cameras
IMAX EPS (Earnings per Share)
IMAX Revenue
Description: IMAX Imax
Imax Corp, listed on the NYSE under the ticker symbol IMAX, is a Canadian company operating in the Movies & Entertainment sub-industry. The companys stock is characterized by its volatility, as reflected in its beta of 0.812, indicating that it is less volatile than the overall market.
Key economic drivers for Imax Corp include the demand for premium cinema experiences, the growth of the global box office, and the adoption of its proprietary technology by cinemas worldwide. The companys revenue is largely dependent on box office performance, as well as the number of its screens installed globally. As a result, KPIs such as the number of screens installed, revenue per screen, and box office growth are crucial in evaluating the companys performance.
From a valuation perspective, Imax Corp has a market capitalization of $1.35 billion and a forward P/E ratio of 20.16, suggesting that the market expects earnings growth in the future. The companys return on equity (RoE) stands at 10.85%, indicating a relatively healthy profitability level. However, the high P/E ratio of 41.98 based on current earnings suggests that the stock may be overvalued if earnings do not meet expectations.
Technical analysis indicates that the stock is currently trading near its resistance levels, with the nearest resistance at $25.6 and $26.7. Support levels are identified at $24.3, $20.7, $16.9, and $15.8, providing potential downside protection. The Average True Range (ATR) of 0.79, equivalent to 3.11%, suggests moderate volatility, which may impact trading strategies.
IMAX Stock Overview
| Market Cap in USD | 1,572m |
| Sub-Industry | Movies & Entertainment |
| IPO / Inception | 1994-06-09 |
IMAX Stock Ratings
| Growth Rating | 79.1% |
| Fundamental | 63.5% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 32.7% |
| Analyst Rating | 4.36 of 5 |
IMAX Dividends
Currently no dividends paidIMAX Growth Ratios
| Growth Correlation 3m | 29.7% |
| Growth Correlation 12m | 73.5% |
| Growth Correlation 5y | 43.2% |
| CAGR 5y | 31.88% |
| CAGR/Max DD 3y | 0.89 |
| CAGR/Mean DD 3y | 3.22 |
| Sharpe Ratio 12m | 1.88 |
| Alpha | 0.00 |
| Beta | 0.983 |
| Volatility | 31.78% |
| Current Volume | 820.4k |
| Average Volume 20d | 1065.8k |
| Stop Loss | 31.4 (-3.1%) |
| Signal | 0.55 |
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (32.8m TTM) > 0 and > 6% of Revenue (6% = 21.7m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 3.41pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 74.48% (prev 59.75%; Δ 14.73pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 76.9m > Net Income 32.8m (YES >=105%, WARN >=100%) |
| Net Debt (168.8m) to EBITDA (109.4m) ratio: 1.54 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.22 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (55.2m) change vs 12m ago 3.24% (target <= -2.0% for YES) |
| Gross Margin 56.88% (prev 55.09%; Δ 1.79pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 42.75% (prev 43.27%; Δ -0.52pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.24 (EBITDA TTM 109.4m / Interest Expense TTM 7.58m) >= 6 (WARN >= 3) |
Altman Z'' 1.88
| (A) 0.31 = (Total Current Assets 490.5m - Total Current Liabilities 220.5m) / Total Assets 868.6m |
| (B) -0.30 = Retained Earnings (Balance) -261.3m / Total Assets 868.6m |
| (C) 0.07 = EBIT TTM 62.5m / Avg Total Assets 848.0m |
| (D) 0.31 = Book Value of Equity 144.5m / Total Liabilities 463.5m |
| Total Rating: 1.88 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.51
| 1. Piotroski 7.0pt = 2.0 |
| 2. FCF Yield 2.72% = 1.36 |
| 3. FCF Margin 13.07% = 3.27 |
| 4. Debt/Equity 0.87 = 2.14 |
| 5. Debt/Ebitda 2.54 = -1.03 |
| 6. ROIC - WACC (= 1.11)% = 1.39 |
| 7. RoE 10.85% = 0.90 |
| 8. Rev. Trend 18.75% = 1.41 |
| 9. EPS Trend 41.55% = 2.08 |
What is the price of IMAX shares?
Over the past week, the price has changed by +4.32%, over one month by +25.79%, over three months by +11.08% and over the past year by +57.23%.
Is Imax a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IMAX is around 34.75 USD . This means that IMAX is currently overvalued and has a potential downside of 7.29%.
Is IMAX a buy, sell or hold?
- Strong Buy: 7
- Buy: 2
- Hold: 1
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the IMAX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 32.8 | 1.3% |
| Analysts Target Price | 32.8 | 1.3% |
| ValueRay Target Price | 38.7 | 19.4% |
Last update: 2025-09-06 04:40
IMAX Fundamental Data Overview
CCE Cash And Equivalents = 109.3m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 48.6833
P/E Forward = 19.7628
P/S = 4.337
P/B = 4.9064
P/EG = 0.8895
Beta = 0.679
Revenue TTM = 362.5m USD
EBIT TTM = 62.5m USD
EBITDA TTM = 109.4m USD
Long Term Debt = 230.5m USD (from longTermDebt, last quarter)
Short Term Debt = 47.5m USD (from shortTermDebt, last quarter)
Debt = 278.0m USD (Calculated: Short Term 47.5m + Long Term 230.5m)
Net Debt = 168.8m USD (from netDebt column, last quarter)
Enterprise Value = 1.74b USD (1.57b + Debt 278.0m - CCE 109.3m)
Interest Coverage Ratio = 8.24 (Ebit TTM 62.5m / Interest Expense TTM 7.58m)
FCF Yield = 2.72% (FCF TTM 47.4m / Enterprise Value 1.74b)
FCF Margin = 13.07% (FCF TTM 47.4m / Revenue TTM 362.5m)
Net Margin = 9.04% (Net Income TTM 32.8m / Revenue TTM 362.5m)
Gross Margin = 56.88% ((Revenue TTM 362.5m - Cost of Revenue TTM 156.3m) / Revenue TTM)
Tobins Q-Ratio = 12.05 (Enterprise Value 1.74b / Book Value Of Equity 144.5m)
Interest Expense / Debt = 0.69% (Interest Expense 1.93m / Debt 278.0m)
Taxrate = 13.25% (5.00m / 37.7m)
NOPAT = 54.2m (EBIT 62.5m * (1 - 13.25%))
Current Ratio = 2.22 (Total Current Assets 490.5m / Total Current Liabilities 220.5m)
Debt / Equity = 0.87 (Debt 278.0m / last Quarter total Stockholder Equity 320.4m)
Debt / EBITDA = 2.54 (Net Debt 168.8m / EBITDA 109.4m)
Debt / FCF = 5.87 (Debt 278.0m / FCF TTM 47.4m)
Total Stockholder Equity = 302.2m (last 4 quarters mean)
RoA = 3.77% (Net Income 32.8m, Total Assets 868.6m )
RoE = 10.85% (Net Income TTM 32.8m / Total Stockholder Equity 302.2m)
RoCE = 11.73% (Ebit 62.5m / (Equity 302.2m + L.T.Debt 230.5m))
RoIC = 9.39% (NOPAT 54.2m / Invested Capital 577.2m)
WACC = 8.28% (E(1.57b)/V(1.85b) * Re(9.64%)) + (D(278.0m)/V(1.85b) * Rd(0.69%) * (1-Tc(0.13)))
Shares Correlation 3-Years: -39.39 | Cagr: -0.14%
Discount Rate = 9.64% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 63.60% ; FCFE base≈35.2m ; Y1≈23.1m ; Y5≈10.6m
Fair Price DCF = 3.02 (DCF Value 162.6m / Shares Outstanding 53.8m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 41.55 | EPS CAGR: 184.7% | SUE: 0.99 | # QB: 1
Revenue Correlation: 18.75 | Revenue CAGR: 11.03% | SUE: N/A | # QB: None
Additional Sources for IMAX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle